Search Results for "Trelstar"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Trelstar. Results 1 to 6 of 6 total matches.
See also: triptorelin
Triptorelin Pamoate (Trelstar)
The Medical Letter on Drugs and Therapeutics • Jun 10, 2002 (Issue 1132)
Triptorelin Pamoate (Trelstar) ...
Two controlled-release formulations of triptorelin (trip toe rel' in) pamoate, an agonist analog of human luteinizing hormone-releasing hormone (LHRH), are now available in the US for parenteral treatment of advanced prostate cancer. Trelstar Depot is given every 4 weeks and Trelstar LA every 12 weeks. Triptorelin has been available in some countries since 1986.
Degarelix (Firmagon) for Prostate Cancer
The Medical Letter on Drugs and Therapeutics • Oct 19, 2009 (Issue 1323)
/12 mos 473.67
Triptorelin –
Trelstar Depot (Pfizer)
7
3.75 mg/28 days IM 726.00
ANTIANDROGENS ...
The FDA has approved degarelix (Firmagon - Ferring), a synthetic decapeptide gonadotropin-releasing hormone (GnRH) receptor antagonist, for rapid medical castration of men with advanced prostate cancer. Abarelix (Plenaxis), the first GnRH antagonist approved by the FDA, was withdrawn from the US market because of immediate hypersensitivity reactions.
Triptorelin (Triptodur) for Central Precocious Puberty
The Medical Letter on Drugs and Therapeutics • Jan 01, 2018 (Issue 1537)
years old. Triptorelin has been available
in the US for years as Trelstar for palliative treatment ...
The FDA has approved an extended-release
intramuscular suspension formulation of the
gonadotropin-releasing hormone (GnRH) agonist
triptorelin (Triptodur – Arbor/Debiopharm) for twice-yearly
treatment of central precocious puberty (CPP)
in children ≥2 years old. Triptorelin has been available
in the US for years as Trelstar for palliative treatment
of advanced prostate cancer. Before the approval
of Triptodur, Trelstar was used off-label for treatment of CPP.
Abarelix (Plenaxis) for Advanced Prostate Cancer
The Medical Letter on Drugs and Therapeutics • Mar 15, 2004 (Issue 1178)
473.67
Triptorelin – Trelstar Depot (Pfizer)
6
3.75 mg/28 days IM 419.60
ANTIANDROGENS
Bicalutamide ...
Abarelix (Plenaxis - Praecis Pharmaceuticals), an injectable gonadotropin-releasing hormone (GnRH) antagonist, has been approved by the FDA for treatment of advanced symptomatic prostate cancer in patients who should not take luteinizing hormone-releasing hormone (LHRH) agonists and who refuse treatment with surgical castration.
Preservation of Ovarian Function During Chemotherapy
The Medical Letter on Drugs and Therapeutics • Jun 28, 2010 (Issue 1341)
in the US: leuprolide acetate (Lupron, and others), nafarelin acetate
(Synarel), triptorelin pamoate (Trelstar ...
Chemotherapy can result in premature menopause and infertility in young women. Pretreatment fertility
counseling followed by appropriate action may prevent some of these undesirable consequences.
Drugs of Choice for Cancer
Treatment Guidelines from The Medical Letter • Mar 01, 2003 (Issue 7)
Triptorelin (Trelstar Depot – Pharmacia) Pain at injection site; tumor flare; bone pain; Decreased libido ...
The tables in this article list drugs used for treatment of cancer in the USA and Canada and their major adverse effects. The choice of drugs in Table I is based on the opinions of Medical Letter consultants. Some drugs are listed for indications for which they have not been approved by the US Food and Drug Administration. In some cases, such as elderly patients or those with many co-morbid illnesses, the regimen of choice might not be suitable. For many of the cancers listed, surgery and/or radiation therapy may be the treatment of choice or may also be part of the management. Anticancer...